You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 43 No. 12, December 1986 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (86)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Alterations in Cerebrospinal Fluid Concentrations of Somatostatinlike Immunoreactivity in Neuropsychiatric Disorders

Garth Bissette, PhD; Erik Widerlöv, MD, PhD; Helena Walléus, MD; Ingvar Karlsson, MD, PhD; Kurt Eklund, MD; Anders Forsman, MD, PhD; Charles B. Nemeroff, MD, PhD

Arch Gen Psychiatry. 1986;43(12):1148-1151.


Abstract



• The concentration of somatostatinlike immunoreactivity in cerebrospinal fluid (CSF) from normal, healthy volunteers (n =10) and patients with DSM-III diagnoses of major depression (n=17), schizophrenia (n =11), or dementia (n =29) was measured by a sensitive and specific radioimmunoassay. Statistically significant decreases in CSF concentrations of somatostatinlike immunoreactivity were seen in all three patient populations when compared with controls. These findings confirm previous reports of decreased concentrations of somatostatinlike immunoreactivity in the CSF of patients with depression and dementia and extend this observation to patients with schizophrenia as well. These findings are concordant with the view that reductions in somatostatinlike immunoreactivity concentrations are associated with diseases in which cognitive function is disturbed.



Author Affiliations



From the Departments of Psychiatry (Drs Bissette and Nemeroff) and Pharmacology (Dr Nemeroff), and the Center for Aging and Human Development (Dr Nemeroff), Duke University Medical Center, Durham, NC; the Department of Psychiatry and Neurochemistry, University of Lund, Lund, Sweden (Dr Widerlöv); the Psychiatric Research Center, University of Uppsala, Uppsala, Sweden (Dr Walleús); the Department of Psychiatry and Neurochemistry (Dr Karlsson), and Lillhagen Hospital Department of Psychiatry (Dr Forsman), University of Gothenburg, Hisings Backa, Gothenburg, Sweden; and Sater Hospital, Sater, Sweden (Dr Eklund).


Footnotes



Accepted for publication July 29, 1986.

Reprint requests to Department of Psychiatry, Box 3859, Duke University Medical Center, Durham, NC 27710 (Dr Bissette).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Somatostatin Immunoreactivity in Postmortem Brain From Depressed Suicides
Charlton et al.
Arch Gen Psychiatry 1988;45:597-597.
ABSTRACT  

Somatostatin Immunoreactivity in Postmortem Brain From Depressed Suicides-Reply
Bissette and Nemeroff
Arch Gen Psychiatry 1988;45:597-598.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.